Found: 54
Select item for more details and to access through your institution.
The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01151-2
- By:
- Publication type:
- Article
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7147, doi. 10.3390/ijms24087147
- By:
- Publication type:
- Article
Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 888, doi. 10.1111/bjh.16462
- By:
- Publication type:
- Article
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 443, doi. 10.1007/s00277-023-05578-8
- By:
- Publication type:
- Article
JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1279, doi. 10.1007/s00277-023-05187-5
- By:
- Publication type:
- Article
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 12, p. 1937, doi. 10.1007/s00277-012-1551-x
- By:
- Publication type:
- Article
BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 5096, doi. 10.3390/jcm10215096
- By:
- Publication type:
- Article
Present and Future Role of Immune Targets in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 253, doi. 10.3390/cancers15010253
- By:
- Publication type:
- Article
Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 330, doi. 10.1111/ejh.13907
- By:
- Publication type:
- Article
Haploidentical transplant after failure of a first allogeneic transplant: A long and winding road.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 871, doi. 10.1111/ejh.13611
- By:
- Publication type:
- Article
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the "GRUPPO TRIVENETO LMC".
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3180, doi. 10.1002/cam4.5158
- By:
- Publication type:
- Article
The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6310, doi. 10.1002/cam4.4179
- By:
- Publication type:
- Article
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 3, p. 269, doi. 10.1111/ejh.12915
- By:
- Publication type:
- Article
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 5, p. 354, doi. 10.1111/j.1600-0609.2008.01122.x
- By:
- Publication type:
- Article
Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 4, p. 293, doi. 10.1111/j.1600-0609.2006.00708.x
- By:
- Publication type:
- Article
Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 3, p. 227, doi. 10.1111/j.1600-0609.2005.00500.x
- By:
- Publication type:
- Article
Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 1, p. 1, doi. 10.1034/j.1600-0609.2003.00084.x
- By:
- Publication type:
- Article
The Role of Allogeneic Transplantation in Chronic Myeloid Leukemia in 2023: A Case-Based Concise Review.
- Published in:
- Hemato, 2023, v. 4, n. 3, p. 250, doi. 10.3390/hemato4030020
- By:
- Publication type:
- Article
Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 1992, v. 48, n. 2, p. 87, doi. 10.1111/j.1600-0609.1992.tb00571.x
- By:
- Publication type:
- Article
Successful treatment of hematological and extramedullary relapse of MLL-positive acute lymphoblastic leukemia after bone marrow transplantation using donor leukocyte infusion.
- Published in:
- 2004
- By:
- Publication type:
- Case Study
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 279, doi. 10.1007/s002800000163
- By:
- Publication type:
- Article
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype.
- Published in:
- Hematological Oncology, 2007, v. 25, n. 1, p. 38, doi. 10.1002/hon.806
- By:
- Publication type:
- Article
Impact of fludarabine-based induction therapy on outcome of FLT3−/ NPM1+ cytogenetically normal acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. E45, doi. 10.1002/ajh.24651
- By:
- Publication type:
- Article
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 784, doi. 10.1002/ajh.24084
- By:
- Publication type:
- Article
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 10, p. 848, doi. 10.1002/ajh.23516
- By:
- Publication type:
- Article
Brain natriuretic peptide level as marker of cardiac function in imatinib-Treated chronic myeloid leukemia patients: No evidence of cardiotoxicity of imatinib therapy.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 6, p. 517, doi. 10.1002/ajh.21157
- By:
- Publication type:
- Article
Epstein‐Barr virus reactivation in a patient treated with anti‐thymocyte globulin for severe aplastic anemia.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 5, p. 355, doi. 10.1002/ajh.20560
- By:
- Publication type:
- Article
CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?
- Published in:
- Biomedicines, 2024, v. 12, n. 6, p. 1194, doi. 10.3390/biomedicines12061194
- By:
- Publication type:
- Article
ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?
- Published in:
- Biomedicines, 2024, v. 12, n. 1, p. 111, doi. 10.3390/biomedicines12010111
- By:
- Publication type:
- Article
Checkpoint Inhibitors in Acute Myeloid Leukemia.
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1724, doi. 10.3390/biomedicines11061724
- By:
- Publication type:
- Article
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 10, p. 2156, doi. 10.1002/cncr.25753
- By:
- Publication type:
- Article
Unexpected phenotype of a typical NPM1 mutant.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Case--control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 1, p. 87, doi. 10.1111/j.1365-2141.2006.06390.x
- By:
- Publication type:
- Article
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 2, p. 172, doi. 10.1111/j.1365-2141.2005.05745.x
- By:
- Publication type:
- Article
Analysis of IgV<sub>H</sub> gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 1, p. 29, doi. 10.1111/j.1365-2141.2004.04985.x
- By:
- Publication type:
- Article
Biological and clinical features of T-biphenotypic acute leukaemia: report from a single centre.
- Published in:
- 2004
- By:
- Publication type:
- Letter
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 3, p. 519, doi. 10.1046/j.0007-1048.2001.03322.x
- By:
- Publication type:
- Article
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
- Published in:
- British Journal of Haematology, 2000, v. 108, n. 4, p. 703, doi. 10.1046/j.1365-2141.2000.01957.x
- By:
- Publication type:
- Article
Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center.
- Published in:
- Turkish Journal of Hematology, 2021, v. 38, n. 2, p. 119, doi. 10.4274/tjh.galenos.2021.2020.0728
- By:
- Publication type:
- Article
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 1, p. 92, doi. 10.1046/j.1365-2141.1999.01505.x
- By:
- Publication type:
- Article
FLOW CYTOMETRY EVALUATION OF PLASMA CELLS CONTAMINATING LEUKAPHERESIS PRE- AND POST-CD34-POSITIVE SELECTION.
- Published in:
- British Journal of Haematology, 1999, v. 105, n. 2, p. 567, doi. 10.1111/j.1365-2141.1999.01418.x
- By:
- Publication type:
- Article
P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.
- Published in:
- British Journal of Haematology, 1999, v. 104, n. 2, p. 328, doi. 10.1046/j.1365-2141.1999.01172.x
- By:
- Publication type:
- Article